Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Bladder Cancer

  Free Subscription


1 Aging (Albany NY)
2 Asian J Urol
1 Biomark Med
1 Biotech Histochem
2 BJU Int
1 BMC Urol
1 Curr Opin Support Palliat Care
1 Curr Opin Urol
1 Eur Rev Med Pharmacol Sci
2 Eur Urol
2 IJU Case Rep
1 Infection
1 Int J Mol Sci
1 Intern Med
1 J Clin Lab Anal
1 J Clin Med
1 J Nippon Med Sch
1 J Transl Med
2 J Urol
1 Mol Cancer Ther
2 Mol Clin Oncol
1 Nat Commun
1 Nutr Cancer
1 Panminerva Med
1 Rev Urol
2 Urol Oncol
1 Urology
1 World J Urol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Aging (Albany NY)

  1. WANG H, Niu X, Jiang H, Mao F, et al
    Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.
    Aging (Albany NY). 2020;12.
    PubMed         Abstract available

    Asian J Urol

  2. XIE W, Bi J, Wei Q, Han P, et al
    Survival after radical cystectomy for bladder cancer: Multicenter comparison between minimally invasive and open approaches.
    Asian J Urol. 2020;7:291-300.
    PubMed         Abstract available

  3. TRIPATHI A, Gupta S
    Androgen receptor in bladder cancer: A promising therapeutic target.
    Asian J Urol. 2020;7:284-290.
    PubMed         Abstract available

    Biomark Med

  4. QUAN J, Zhang W, Yu C, Bai Y, et al
    Bioinformatic identification of prognostic indicators in bladder cancer.
    Biomark Med. 2020 Aug 4. doi: 10.2217/bmm-2020-0316.
    PubMed         Abstract available

    Biotech Histochem

  5. KARIMI M, Heshmati M, Fattahi S, Bagheri N, et al
    The relation between the ghrelin receptor and FOXP3 in bladder cancer.
    Biotech Histochem. 2020 Aug 3:1-9. doi: 10.1080/10520295.2020.1799074.
    PubMed         Abstract available

    BJU Int

  6. ALJABERY F, Liedberg F, Haggstrom C, Strock V, et al
    Treatment and prognosis of bladder cancer patients with other primary cancers. A nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe).
    BJU Int. 2020 Aug 6. doi: 10.1111/bju.15198.
    PubMed         Abstract available

  7. GONTERO P, Montanari E, Roupret M, Longo F, et al
    Comparison of the performance of ADXBLADDER test and urinary Cytology in the follow up of Non-Muscle Invasive Bladder Cancer: a blinded prospective multicentric study.
    BJU Int. 2020 Aug 3. doi: 10.1111/bju.15194.
    PubMed         Abstract available

    BMC Urol

  8. HUANG WL, Huang KH, Huang CY, Pu YS, et al
    Effect of diabetes mellitus and glycemic control on the prognosis of non-muscle invasive bladder cancer: a retrospective study.
    BMC Urol. 2020;20:117.
    PubMed         Abstract available

    Curr Opin Support Palliat Care

  9. DESILETS A, Adam JP, Soulieres D
    Management of cisplatin-associated toxicities in bladder cancer patients.
    Curr Opin Support Palliat Care. 2020 Jul 23. doi: 10.1097/SPC.0000000000000505.
    PubMed         Abstract available

    Curr Opin Urol

  10. Bladder-preserving strategies for Bacillus Calmette-Guerin unresponsive non-muscle invasive bladder cancer; where are we and what will be expected?: Erratum.
    Curr Opin Urol. 2020;30:746.

    Eur Rev Med Pharmacol Sci

  11. LIU H, Chang JK, Hou JQ, Zhao ZH, et al
    Inhibition of miR-221 influences bladder cancer cell proliferation and apoptosis.
    Eur Rev Med Pharmacol Sci. 2020;24:7550.
    PubMed         Abstract available

    Eur Urol

  12. MONTORSI F, Bandini M, Briganti A, Dasgupta P, et al
    Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel Recommendations.
    Eur Urol. 2020 Jul 28. pii: S0302-2838(20)30464.
    PubMed         Abstract available

  13. LINDGREN MS, Bue P, Azawi N, Blichert-Refsgaard L, et al
    The DaBlaCa-13 Study: Short-term, Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in Non-muscle-invasive Bladder Cancer-A Randomised Controlled Trial.
    Eur Urol. 2020 Jul 28. pii: S0302-2838(20)30541.
    PubMed         Abstract available

    IJU Case Rep

    Editorial Comment to Pembrolizumab-induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer.
    IJU Case Rep. 2019;3:20.

  15. TODO M, Kaneko G, Shirotake S, Shimada Y, et al
    Pembrolizumab-induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer.
    IJU Case Rep. 2019;3:17-20.
    PubMed         Abstract available


  16. DUBERT M, Abihssira S, Diamantis S, Guenin R, et al
    Mycobacterium bovis infection of an aortobifemoral bypass graft with Streptococcus intermedius superinfection after intravesical bacillus Calmette-Guerin immunotherapy for bladder cancer.
    Infection. 2020 Aug 4. pii: 10.1007/s15010-020-01495.
    PubMed         Abstract available

    Int J Mol Sci

  17. JUSTIN S, Rutz J, Maxeiner S, Chun FK, et al
    Bladder Cancer Metastasis Induced by Chronic Everolimus Application Can Be Counteracted by Sulforaphane In Vitro.
    Int J Mol Sci. 2020;21.
    PubMed         Abstract available

    Intern Med

  18. MINAKATA T, Nakano Y, Tamura S, Kazuki Y, et al
    Tuberculous Spondylitis Caused by Intravesical Bacillus Calmette-Guerin Therapy.
    Intern Med. 2020;59:733-737.
    PubMed         Abstract available

    J Clin Lab Anal

  19. WANG J, Zhao L, Peng X, Liu K, et al
    Evaluation of miR-130 family members as circulating biomarkers for the diagnosis of bladder cancer.
    J Clin Lab Anal. 2020 Aug 5:e23517. doi: 10.1002/jcla.23517.
    PubMed         Abstract available

    J Clin Med

  20. COSTANTINI L, Molinari R, Farinon B, Lelli V, et al
    Docosahexaenoic Acid Reverted the All-trans Retinoic Acid-Induced Cellular Proliferation of T24 Bladder Cancer Cell Line.
    J Clin Med. 2020;9.
    PubMed         Abstract available

    J Nippon Med Sch

  21. TAKAHASHI K, Kimura G, Endo Y, Akatsuka J, et al
    Urothelial Carcinoma of the Bladder, Lipid Cell Variant: Case Report and Literature Review.
    J Nippon Med Sch. 2020;86:349-351.
    PubMed         Abstract available

    J Transl Med

  22. LOBO J, Monteiro-Reis S, Guimaraes-Teixeira C, Lopes P, et al
    Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression.
    J Transl Med. 2020;18:303.
    PubMed         Abstract available

    J Urol

  23. VAN KESSEL KEM, de Jong JJ, Ziel-van der Made ACJ, Roshani H, et al
    A Urine Based Genomic Assay to Triage Patients with Hematuria for Cystoscopy.
    J Urol. 2020;204:50-57.
    PubMed         Abstract available

  24. MORI K, Mostafaei H, Enikeev DV, Lysenko I, et al
    Differential Effect of Sex on Outcomes after Radical Surgery for Upper Tract and Bladder Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
    J Urol. 2020;204:58-62.
    PubMed         Abstract available

    Mol Cancer Ther

  25. MIZUSHIMA T, Jiang G, Kawahara T, Li P, et al
    Androgen Receptor Signaling Reduces the Efficacy of Bacillus Calmette-Guerin Therapy for Bladder Cancer via Modulating Rab27b-induced Exocytosis.
    Mol Cancer Ther. 2020 Jul 31. pii: 1535-7163.MCT-20-0050.
    PubMed         Abstract available

    Mol Clin Oncol

  26. KURODA K, Tasaki S, Sato A, Asakuma J, et al
    Effect of continuous saline bladder irrigation with concomitant single instillation of chemotherapy after transurethral resection on intravesical recurrence in patients with non-muscle-invasive bladder cancer.
    Mol Clin Oncol. 2020;13:6.
    PubMed         Abstract available

  27. MATSUSHITA Y, Tamura K, Motoyama D, Ito T, et al
    Comprehensive assessment of oncological outcomes in 186 patients with high-risk non-muscle-invasive bladder cancer: A single institution retrospective study.
    Mol Clin Oncol. 2020;13:16.
    PubMed         Abstract available

    Nat Commun

  28. KIM K, Hu W, Audenet F, Almassi N, et al
    Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts.
    Nat Commun. 2020;11:1975.
    PubMed         Abstract available

    Nutr Cancer

  29. MOSTAFAEI S, Riahi P
    Interaction Effects of Plasma Vitamins A, E, D, B9, and B12 and Tobacco Exposure in Urothelial Bladder Cancer: A Multifactor Dimensionality Reduction Analysis.
    Nutr Cancer. 2020 Aug 6:1-2. doi: 10.1080/01635581.2020.1801776.

    Panminerva Med

  30. ZHAO B, Wang K, Jiang B
    Application of clinical nursing pathway in bladder cancer patients undergoing ureteroperitoneostomy.
    Panminerva Med. 2020 Aug 5. pii: S0031-0808.20.04010.

    Rev Urol

  31. MATULEWICZ RS, Steinberg GD
    Non-muscle-invasive Bladder Cancer: Overview and Contemporary Treatment Landscape of Neoadjuvant Chemoablative Therapies.
    Rev Urol. 2020;22:43-51.
    PubMed         Abstract available

    Urol Oncol

  32. TULLY KH, Moschini M, von Rundstedt FE, Aziz A, et al
    Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer - examining the utility of classifying Ta bladder cancer based on size.
    Urol Oncol. 2020 Jul 29. pii: S1078-1439(20)30321.
    PubMed         Abstract available

  33. GONZALEZ-PADILLA DA, Gonzalez-Diaz A, Guerrero-Ramos F, Rodriguez-Serrano A, et al
    Quality of life and adverse events in patients with nonmuscle invasive bladder cancer receiving adjuvant treatment with BCG, MMC, or chemohyperthermia.
    Urol Oncol. 2020 Aug 1. pii: S1078-1439(20)30325.
    PubMed         Abstract available


  34. KAYE DR, Schafer C, Thelen-Perry S, Parker C, et al
    The feasibility and impact of a pre-surgical exercise intervention program (prehabilitation) for patients undergoing cystectomy for bladder cancer.
    Urology. 2020 Jul 30. pii: S0090-4295(20)30933.
    PubMed         Abstract available

    World J Urol

  35. DE LA CALLE CM, Washington SL 3rd, Lonergan PE, Meng MV, et al
    Bladder cancer in patients younger than 40 years: outcomes from the National Cancer Database.
    World J Urol. 2020 Jul 31. pii: 10.1007/s00345-020-03376.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.